Back to Authors

Zago, Wagner

https://orcid.org/0009-0002-5244-5098

A5036297287 | I4210092380

Mayo Clinic

Prothena (United States)

Citations 2

PRX004 in variant amyloid transthyretin (ATTRv) amyloidosis: results of a phase 1, open-label, dose-escalation study

Amyloid | October 30, 2024 | Volume: 32 | Issue: 1 | Pages: 14-21

10.1080/13506129.2024.2420809 | PMID 39472768

The mechanism of action, pharmacological characteristics, and clinical utility of the amyloid depleter birtamimab for the potential treatment of AL amyloidosis

Leukemia & Lymphoma | April 11, 2024 | Volume: 65 | Issue: 8 | Pages: 1068-1078

10.1080/10428194.2024.2337803 | PMID 38600883